What is Biote Corp share price today?

Biote Corp (BTMD) share price today is {{live_price}}.

Can Indians buy Biote Corp shares?

Yes, Indians can invest in the Biote Corp (BTMD) from India. With INDmoney, you can buy Biote Corp at 0 brokerage. The step-by-step process is as follows: Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes) Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates. Once funds are transferred successfully, you can buy Biote Corp at zero transaction cost.

How can I buy Biote Corp shares from India?

It is very easy to buy Biote Corp from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Biote Corp be purchased?

Yes, you can buy fractional shares of Biote Corp with INDmoney app.

What are the documents required to start investing in Biote Corp stocks?

To start investing in Biote Corp, You will need the following documents: Proof of Identification (PAN, Aadhaar etc) Proof of address (Aadhaar, Voter ID etc) These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

What are today’s High and Low prices of Biote Corp

Today’s highest price of Biote Corp (BTMD) is {{1_rba_end}}. Today’s lowest price of Biote Corp (BTMD) is {{1_rba_st}}.

What is today's market capitalisation of Biote Corp

Today's market capitalisation of Biote Corp BTMD is 274.2M

What is the 52 Week High and Low Range of Biote Corp

52 Week High {{rba_end}} 52 Week Low {{rba_st}}

How much percentage Biote Corp is down from its 52 Week High?

Biote Corp (BTMD) share price is {{live_price}}. It is down by {{w52lu}}% from its 52 Week High price of {{rba_end}}.

How much percentage Biote Corp is up from its 52 Week low?

Biote Corp (BTMD) share price is {{live_price}}. It is up by {{w52hd}}% from its 52 Week Low price of {{rba_st}}.

What are the historical returns of Biote Corp?

1 Month Returns {{1mr}}% 3 Months Returns {{3mr}}% 1 Year Returns {{1yr}}% 5 Years Returns {{5yr}}%

Who is the Chief Executive Officer (CEO) of Biote Corp

Mr. Marc D. Beer is the current Chief Executive Officer (CEO) of Biote Corp.

Biote Corp share price: BTMD Stock Price live today

Performance

$5.10
$5.30
$5.21
2.11%
Downside
Day's Volatility :3.77%
Upside
1.7%
$3.65
$8.44
$5.21
29.87%
Downside
52 Weeks Volatility :56.71%
Upside
38.27%

Returns

Period	Biote Corp	Index (Russel 2000)
3 Months	-33.21%	0.0%
6 Months	-14.17%	0.0%
1 Year	-2.43%	0.0%
3 Years	22.88%	-20.8%

Highlights

Market Capitalization	274.2M
Book Value	- $4.62
Earnings Per Share (EPS)	0.5
PE Ratio	10.42
Wall Street Target Price	9.59

Profit Margin	3.67%
Operating Margin TTM	16.55%

Return On Assets TTM	20.54%
Return On Equity TTM	0.0%

Revenue TTM	187.2M
Revenue Per Share TTM	5.64
Quarterly Revenue Growth YOY	-0.2%
Gross Profit TTM	90.6M
EBITDA	39.3M
Diluted Eps TTM	0.5
Quarterly Earnings Growth YOY	3.42

EPS Estimate Current Year	-0.02
EPS Estimate Next Year	0.57
EPS Estimate Current Quarter	0.09
EPS Estimate Next Quarter	0.1

Analyst Recommendation

Buy

90%Buy

9%Hold

0

0%Sell

Based on 11 Wall street analysts offering stock ratings for Biote Corp(by analysts ranked 0 to 5 stars)

Based on 11 analyst

Current
1M Ago
3M Ago

Buy

10

8

Hold

1

Sell

00

Analyst Forecast

What analysts predicted

Upside of 84.07%

Current $5.21

Target $9.59

Company Financials

	FY19	Y/Y Change
Revenue	110.0M	-
Net Income	21.3M	-
Net Profit Margin	19.36%	-

	FY20	Y/Y Change
Revenue	116.6M	↑ 5.99%
Net Income	29.2M	↑ 36.99%
Net Profit Margin	25.02%	↑ 5.66%

	FY21	Y/Y Change
Revenue	139.4M	↑ 19.58%
Net Income	32.6M	↑ 11.85%
Net Profit Margin	23.4%	↓ 1.62%

	FY22	Y/Y Change
Revenue	165.0M	↑ 18.34%
Net Income	1.3M	↓ 95.94%
Net Profit Margin	0.8%	↓ 22.6%

	FY23	Y/Y Change
Revenue	185.4M	↑ 12.37%
Net Income	3.3M	↑ 150.45%
Net Profit Margin	1.79%	↑ 0.99%

	Q1 FY23	Q/Q Change
Revenue	44.8M	↑ 0.8%
Net Income	-21.4M	↓ 267.3%
Net Profit Margin	-47.79%	↓ 76.58%

	Q2 FY23	Q/Q Change
Revenue	49.3M	↑ 9.84%
Net Income	-5.1M	↓ 76.0%
Net Profit Margin	-10.44%	↑ 37.35%

	Q3 FY23	Q/Q Change
Revenue	45.6M	↓ 7.51%
Net Income	7.5M	↓ 246.41%
Net Profit Margin	16.53%	↑ 26.97%

	Q4 FY23	Q/Q Change
Revenue	45.7M	↑ 0.32%
Net Income	7.7M	↑ 2.71%
Net Profit Margin	16.92%	↑ 0.39%

	Q1 FY24	Q/Q Change
Revenue	46.8M	↑ 2.41%
Net Income	-2.1M	↓ 126.76%
Net Profit Margin	-4.42%	↓ 21.34%

	Q2 FY24	Q/Q Change
Revenue	49.2M	↑ 5.05%
Net Income	-6.3M	↑ 205.41%
Net Profit Margin	-12.86%	↓ 8.44%

	FY19	Y/Y Change
Total Assets	23.9M	-
Total Liabilities	56.8M	-

	FY20	Y/Y Change
Total Assets	32.6M	↑ 36.4%
Total Liabilities	49.7M	↓ 12.6%

	FY21	Y/Y Change
Total Assets	54.3M	↑ 66.72%
Total Liabilities	50.2M	↑ 1.09%

	FY22	Y/Y Change
Total Assets	111.6M	↑ 105.49%
Total Liabilities	169.9M	↑ 238.45%

	FY23	Y/Y Change
Total Assets	155.3M	↑ 39.1%
Total Liabilities	191.8M	↑ 12.9%

	Q1 FY23	Q/Q Change
Total Assets	119.1M	↑ 6.71%
Total Liabilities	202.9M	↑ 19.44%

	Q2 FY23	Q/Q Change
Total Assets	139.1M	↑ 16.72%
Total Liabilities	212.3M	↑ 4.61%

	Q3 FY23	Q/Q Change
Total Assets	149.7M	↑ 7.69%
Total Liabilities	201.0M	↓ 5.31%

	Q4 FY23	Q/Q Change
Total Assets	155.3M	↑ 3.7%
Total Liabilities	191.8M	↓ 4.56%

	Q1 FY24	Q/Q Change
Total Assets	160.1M	↑ 3.1%
Total Liabilities	205.0M	↑ 6.86%

	Q2 FY24	Q/Q Change
Total Assets	92.9M	↓ 41.98%
Total Liabilities	234.6M	↑ 14.41%

	FY19	Y/Y Change
Operating Cash Flow	25.4M	-
Investing Cash Flow	-1.7M	-
Financing Cash Flow	-13.6M	-

	FY20	Y/Y Change
Operating Cash Flow	26.4M	↑ 4.22%
Investing Cash Flow	-1.4M	↓ 16.69%
Financing Cash Flow	-18.3M	↑ 35.17%

	FY21	Y/Y Change
Operating Cash Flow	33.7M	↑ 27.61%
Investing Cash Flow	-3.8M	↑ 173.3%
Financing Cash Flow	-20.3M	↑ 11.05%

	Q1 FY23	Q/Q Change
Operating Cash Flow	13.0M	↑ 114.71%
Investing Cash Flow	-380.0K	↑ 22.19%
Financing Cash Flow	-4.2M	↑ 6.51%

	Q2 FY23	Q/Q Change
Operating Cash Flow	6.8M	↓ 47.85%
Investing Cash Flow	-20.8M	↑ 5385.53%
Financing Cash Flow	-5.1M	↑ 19.43%

Technicals Summary

Sell

Neutral

Buy

Biote Corp is currently in a neutral trading position according to technical analysis indicators.

Peers

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
Biote Corp	-15.7%	-14.17%	-2.43%	22.88%	22.88%
Fresenius Medical Care Ag	0.55%	7.02%	-3.66%	-41.17%	-38.78%
Hca Holdings, Inc.	-0.63%	15.11%	52.07%	59.39%	222.06%
Tenet Healthcare Corp.	-1.61%	48.07%	145.72%	143.15%	596.3%
Universal Health Services Inc.	-6.19%	23.91%	63.22%	63.34%	46.43%
Davita Healthcare Partners Inc.	4.86%	17.5%	78.01%	41.24%	185.35%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
Biote Corp	10.26	10.26	NA	-0.02	0.0	0.21	NA	-4.62
Fresenius Medical Care Ag	20.7	20.7	0.42	2.31	0.05	0.03	0.03	47.48
Hca Holdings, Inc.	17.95	17.95	1.19	22.61	0.74	0.11	0.01	-6.17
Tenet Healthcare Corp.	5.57	5.57	0.8	10.57	0.55	0.07	NA	36.27
Universal Health Services Inc.	15.63	15.63	1.87	15.95	0.15	0.06	0.0	97.21
Davita Healthcare Partners Inc.	16.74	16.74	1.47	9.8	0.45	0.07	NA	7.44

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
Biote Corp	Buy	$270.0M	22.88%	10.26	3.67%
Fresenius Medical Care Ag	Hold	$12.2B	-38.78%	20.7	2.73%
Hca Holdings, Inc.	Buy	$98.7B	222.06%	17.95	8.4%
Tenet Healthcare Corp.	Buy	$14.6B	596.3%	5.57	13.18%
Universal Health Services Inc.	Hold	$14.2B	46.43%	15.63	6.22%
Davita Healthcare Partners Inc.	Hold	$13.2B	185.35%	16.74	6.86%

Insights on Biote Corp

Increasing Revenue
Revenue is up for the last 4 quarters, 45.55M → 49.16M (in $), with an average increase of 2.5% per quarter
Decreasing Net Profit
Netprofit is down for the last 3 quarters, 7.73M → -6.32M (in $), with an average decrease of 166.1% per quarter
Vs THC
In the last 1 year, Tenet Healthcare Corp. has given 145.7% return, outperforming this stock by 148.1%